Miranda H Meeuwsen

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

Long Non Coding Rna

Top Venues

Journal for immunotherapy of cancer

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

Tom J Harryvan, Marten Visser, Linda de Bruin, Léonie Plug, Lisa Griffioen, Arend Mulder, Peter A van Veelen, Gerbrand J van der Heden van Noort, Marlieke Lm Jongsma, Miranda H Meeuwsen, Emmanuel Jhj Wiertz, Saskia J A M Santegoets, James Ch Hardwick, Thorbald van Hall, Jacques Neefjes, Sjoerd H Van der Burg, Lukas J A C Hawinkels, Elizabeth M E Verdegaal
Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S. Journal for immunotherapy of cancer 10 (3) (2022)
Miranda H Meeuwsen, Anne K Wouters, Renate S Hagedoorn, Michel G D Kester, Dennis F G Remst, Dirk M van der Steen, Arnoud de Ru, Peter A van Veelen, Jamie Rossjohn, Stephanie Gras, J H Frederik Falkenburg, Mirjam H M Heemskerk
Cutting Edge: Unconventional CD8 + T Cell Recognition of a Naturally Occurring HLA-A*02:01-Restricted 20mer Epitope. Journal of immunology (Baltimore, Md. : 1950) 208 (8) (2022)
Tassilo L A Wachsmann, Anne K Wouters, Dennis F G Remst, Renate S Hagedoorn, Miranda H Meeuwsen, Eline van Diest, Jeanette H W Leusen, Jürgen H E Kuball, J H Frederik Falkenburg, Mirjam H M Heemskerk
Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure. Oncoimmunology 11 (1) (2022)
Laura T Morton, Tassilo L A Wachsmann, Miranda H Meeuwsen, Anne K Wouters, Dennis F G Remst, Marleen M van Loenen, J H Frederik Falkenburg, Mirjam H M Heemskerk
T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion. Journal for immunotherapy of cancer 10 (3) (2022)